Tag: myotonic dystrophy type 1

Niraparib may lengthen progression-free survival for patients with recurrent ovarian cancer

Safety and efficacy of novel antibody-oligonucleotide therapy for myotonic dystrophy type 1

byRomila Santraand1 others

February 25, 2026

1. In this phase 1-2 randomized controlled trial involving adults with myotonic dystrophy type 1, del-desiran was well-tolerated in most ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

Delivery of evidence-based interventions for alcohol misuse in the emergency department is low
New guidelines limit hypertension treatment in adults over 65
Millions of Americans became first-time gun owners post-pandemic

No Result

View All Result